Literature DB >> 17114463

Analysis of the individual contributions of Igalpha (CD79a)- and Igbeta (CD79b)-mediated tonic signaling for bone marrow B cell development and peripheral B cell maturation.

Ezequiel M Fuentes-Pananá1, Gregory Bannish, Fredrick G Karnell, John F Treml, John G Monroe.   

Abstract

The individual contribution of Igalpha and Igbeta for BCR-triggered fates is unclear. Prior evidence supports conflicting ideas concerning unique as well as redundant functions for these proteins in the context of BCR/pre-BCR signaling. Part of this ambiguity may reflect the recent appreciation that Igalpha and Igbeta participate in both Ag-independent (tonic) and Ag-dependent signaling. The present study undertook defining the individual requirement for Igalpha and Igbeta under conditions where only ligand-independent tonic signaling was operative. In this regard, we have constructed chimeric proteins containing one or two copies of the cytoplasmic domains of either Igalpha or Igbeta and Igalpha/Igbeta heterodimers with targeted Tyr-->Phe modifications. The ability of these proteins to act as surrogate receptors and trigger early bone marrow and peripheral B cell maturation was tested in RAG2(-/-) primary pro-B cell lines and in gene transfer experiments in the muMT mouse model. We considered that the threshold for a functional activity mediated by the pre-BCR/BCR might only be reached when two functional copies of the Igalpha/Igbeta ITAM domain are expressed together, and therefore the specificity conferred by these proteins can only be observed in these conditions. We found that the ligand-independent tonic signal is sufficient to drive development into mature follicular B cells and both Igalpha and Igbeta chains supported formation of this population. In contrast, neither marginal zone nor B1 mature B cell subsets develop from bone marrow precursors under conditions where only tonic signals are generated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17114463     DOI: 10.4049/jimmunol.177.11.7913

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review.

Authors:  Rosalba Camicia; Hans C Winkler; Paul O Hassa
Journal:  Mol Cancer       Date:  2015-12-11       Impact factor: 27.401

2.  IFN regulatory factor 8 restricts the size of the marginal zone and follicular B cell pools.

Authors:  Jianxun Feng; Hongsheng Wang; Dong-Mi Shin; Marek Masiuk; Chen-Feng Qi; Herbert C Morse
Journal:  J Immunol       Date:  2010-12-22       Impact factor: 5.422

3.  Differential regulation of TLR4 expression in human B cells and monocytes.

Authors:  Lisa M Ganley-Leal; YanMei Liang; Madhumita Jagannathan-Bogdan; Francis A Farraye; Barbara S Nikolajczyk
Journal:  Mol Immunol       Date:  2010-10-16       Impact factor: 4.407

4.  B cell receptor accessory molecules in the channel catfish, Ictalurus punctatus.

Authors:  Manoranjan Sahoo; Eva-Stina Edholm; James L Stafford; Eva Bengtén; Norman W Miller; Melanie Wilson
Journal:  Dev Comp Immunol       Date:  2008-06-10       Impact factor: 3.636

5.  Oncogene-independent BCR-like signaling adaptation confers drug resistance in Ph-like ALL.

Authors:  Christian Hurtz; Gerald B Wertheim; Joseph P Loftus; Daniel Blumenthal; Anne Lehman; Yong Li; Asen Bagashev; Bryan Manning; Katherine D Cummins; Janis K Burkhardt; Alexander E Perl; Martin Carroll; Sarah K Tasian
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

6.  B cell depletion with anti-CD79 mAbs ameliorates autoimmune disease in MRL/lpr mice.

Authors:  Yongmei Li; Fangqi Chen; Mary Putt; Yumee K Koo; Michael Madaio; John C Cambier; Philip L Cohen; Robert A Eisenberg
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

7.  Tonic B-cell receptor signaling in diffuse large B-cell lymphoma.

Authors:  Ondrej Havranek; Jingda Xu; Stefan Köhrer; Zhiqiang Wang; Lisa Becker; Justin M Comer; Jared Henderson; Wencai Ma; John Man Chun Ma; Jason R Westin; Dipanjan Ghosh; Nicholas Shinners; Luhong Sun; Allen F Yi; Anusha R Karri; Jan A Burger; Tomasz Zal; R Eric Davis
Journal:  Blood       Date:  2017-06-23       Impact factor: 22.113

8.  Association of reactive oxygen species-mediated signal transduction with in vitro apoptosis sensitivity in chronic lymphocytic leukemia B cells.

Authors:  Adam L Palazzo; Erik Evensen; Ying-Wen Huang; Alessandra Cesano; Garry P Nolan; Wendy J Fantl
Journal:  PLoS One       Date:  2011-10-10       Impact factor: 3.240

9.  Expression of the B-cell receptor component CD79a on immature myeloid cells contributes to their tumor promoting effects.

Authors:  Dror Luger; Yu-An Yang; Asaf Raviv; Douglas Weinberg; Subhadra Banerjee; Min-Jung Lee; Jane Trepel; Li Yang; Lalage M Wakefield
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.